These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20795753)

  • 21. Disease-modifying treatments for progressive multiple sclerosis.
    Comi G
    Mult Scler; 2013 Oct; 19(11):1428-36. PubMed ID: 24062415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of complementary and alternative medicine in therapy of multiple sclerosis.
    Kes VB; Cesarik M; Matovina LZ; Zavoreo I; Corić L; Drnasin S; Demarin V
    Acta Clin Croat; 2013 Dec; 52(4):464-71. PubMed ID: 24696997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging therapies for MS.
    Waubant E
    Rev Neurol (Paris); 2007 Jun; 163(6-7):688-96. PubMed ID: 17607191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and treatment trials in multiple sclerosis.
    Kieseier BC; Wiendl H; Hemmer B; Hartung HP
    Curr Opin Neurol; 2007 Jun; 20(3):286-93. PubMed ID: 17495622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R; Arnon R
    Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory drug treatment in multiple sclerosis.
    Aharoni R
    Expert Rev Neurother; 2010 Sep; 10(9):1423-36. PubMed ID: 20819013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trials in multiple sclerosis.
    Cutter G; Kappos L
    Handb Clin Neurol; 2014; 122():445-53. PubMed ID: 24507530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fat-soluble vitamins as disease modulators in multiple sclerosis.
    Torkildsen Ø; Løken-Amsrud KI; Wergeland S; Myhr KM; Holmøy T
    Acta Neurol Scand Suppl; 2013; (196):16-23. PubMed ID: 23190287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New therapeutic approaches for multiple sclerosis.
    De Jager PL; Hafler DA
    Annu Rev Med; 2007; 58():417-32. PubMed ID: 17217332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS; Weiner HL
    Nat Rev Drug Discov; 2008 Nov; 7(11):909-25. PubMed ID: 18974749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy in multiple sclerosis.
    Fernández O
    J Neurol Sci; 2007 Aug; 259(1-2):95-103. PubMed ID: 17507031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent clinical trials and future therapies.
    Meuth SG; Kleinschnitz C; Wiendl H
    J Neurol; 2008 Dec; 255 Suppl 6():93-6. PubMed ID: 19300967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Overview of the recent clinical trials in severe head injury and analysis of their therapeutic failure].
    Boto GR; Gómez PA; De la Cruz J; Lobato RD
    Neurocirugia (Astur); 2005 Feb; 16(1):39-49. PubMed ID: 15756410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancement of therapies for neuroprotection in multiple sclerosis.
    Lo A
    Expert Rev Neurother; 2008 Sep; 8(9):1355-66. PubMed ID: 18759548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiple sclerosis at the time of world-wide use of disease modifying treatment].
    Gusev EI; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):4-9. PubMed ID: 19894306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of statins in the treatment of multiple sclerosis.
    Ciurleo R; Bramanti P; Marino S
    Pharmacol Res; 2014 Sep; 87():133-43. PubMed ID: 24657241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapies for multiple sclerosis: translational achievements and outstanding needs.
    Haghikia A; Hohlfeld R; Gold R; Fugger L
    Trends Mol Med; 2013 May; 19(5):309-19. PubMed ID: 23582699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis: new insights in pathogenesis and novel therapeutics.
    Ontaneda D; Hyland M; Cohen JA
    Annu Rev Med; 2012; 63():389-404. PubMed ID: 21888515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alternative and complementary therapies in multiple sclerosis].
    Schwarz S; Leweling H; Meinck HM
    Fortschr Neurol Psychiatr; 2005 Aug; 73(8):451-62. PubMed ID: 16052439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of multiple sclerosis treatment.
    Cohen JA
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.